Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
Oncology Today with Dr Neil Love
00:00
Community Adoption Expectations
Hanny estimates about 60% of colleagues would adopt his approach with yonalimab, while others may differ in practice patterns.
Play episode from 07:28
Transcript
